While technology such as continuous glucose monitoring (CGM) and advanced automated insulin delivery (AID) systems have been very helpful in improving control of glucose and prevention of hypoglycemia, the burden of self‐management remains very high for patients, their families, and multidisciplinary care teams.10 This evidence concerns the gene INS and Hypoglycemia.